To include your compound in the COVID-19 Resource Center, submit it here.

BioCryst, Idera merging

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) said Jan. 22 it will merge with Idera Pharmaceuticals Inc. (NASDAQ:IDRA) to form a company focused on rare diseases. The combined company will be renamed when the merger closes, which is

Read the full 358 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE